EndoGastric Solutions Secures $30.5 Million In New Financing »
July 10, 2018
Existing and New Investors Participated in Support of Rapid Commercialization Redmond, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that it has secured $30.5 million in new financing led by existing EGS investors Advanced Technology Ventures (ATV), Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius […] More »
EndoGastric Solutions Announces New Data Demonstrating the Feasibility, Safety and Efficacy of EsophyX® Z Device in TIF 2.0 Procedure Following Peroral Endoscopic Myotomy »
June 26, 2018
TIF 2.0 Procedure improves symptoms and esophagitis while reducing acid exposure and decreasing risk associated with long-term proton pump inhibitor use for POEM patients REDMOND, Wash – EndoGastric® Solutions today announced the publication of new clinical data demonstrating the safety and efficacy of the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure in patients with achalasia who have […] More »
EndoGastric Solutions Announces New Data at Digestive Disease Week 2018 Supporting the Durability and Efficacy of TIF 2.0 Procedure for GERD Patients »
June 2, 2018
TIF 2.0 procedure provides improved quality of life and elimination of daily PPI use for up to 10 years in patients with symptomatic GERD; TIF 2.0 procedure combined with laparoscopic hiatal hernia repair is a safe and effective option for patients with severe GERD and hiatal hernia REDMOND, Wash – EndoGastric® Solutions today announced the […] More »
EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients »
May 31, 2018
TIF Procedure offers excellent short and long-term relief for the majority of chronic GERD patients. REDMOND, Wash – EndoGastric® Solutions today announced the publication of a meta-analysis supporting the clinical utility of Transoral Incisionless Fundoplication (TIF®) 2.0 in the treatment of refractory gastroesophageal reflux disease (GERD). The TIF 2.0 procedure is a minimally invasive endoscopic option […] More »
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 15
- Next Page »